These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23462961)

  • 1. Antiproliferative, antiinvasive, and proapoptotic activity of folate receptor α-targeted liposomal doxorubicin in nonfunctional pituitary adenoma cells.
    Liu X; Ma S; Dai C; Cai F; Yao Y; Yang Y; Feng M; Deng K; Li G; Ma W; Xin B; Lian W; Xiang G; Zhang B; Wang R
    Endocrinology; 2013 Apr; 154(4):1414-23. PubMed ID: 23462961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate receptor-mediated drug targeting: a possible strategy for nonfunctioning pituitary adenomas?
    Lee M; Pellegata NS
    Endocrinology; 2013 Apr; 154(4):1387-9. PubMed ID: 23525581
    [No Abstract]   [Full Text] [Related]  

  • 3. Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas.
    Dai C; Cai F; Hwang KC; Zhou Y; Zhang Z; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wei J; Jiao Y; Wei Z; Ma W; Wang R
    Sci China Life Sci; 2013 Feb; 56(2):163-73. PubMed ID: 23334699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
    Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of folate receptor alpha in pituitary adenomas and its relationship to tumor behavior.
    Liu X; Ma S; Yao Y; Li G; Feng M; Deng K; Dai C; Cai F; Li Y; Zhang B; Wang R
    Neurosurgery; 2012 May; 70(5):1274-80; discussion 1280. PubMed ID: 22089756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
    Pan XQ; Wang H; Lee RJ
    Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
    Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
    Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
    Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dual-Targeting Octaguanidine-Doxorubicin Conjugate Transporter for Inducing Caspase-Mediated Apoptosis on Folate-Expressing Cancer Cells.
    Nair JB; Joseph MM; Mohapatra S; Safeera M; Ghosh S; Sreelekha TT; Maiti KK
    ChemMedChem; 2016 Apr; 11(7):702-12. PubMed ID: 26990462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
    Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin.
    Gupta B; Pathak S; Poudel BK; Regmi S; Ruttala HB; Gautam M; Lee JS; Jeong JH; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 Jul; 155():83-92. PubMed ID: 28410515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas.
    Fernando MA; Heaney AP
    Mol Endocrinol; 2005 Dec; 19(12):3085-96. PubMed ID: 16020484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells.
    Banerjee R; Tyagi P; Li S; Huang L
    Int J Cancer; 2004 Nov; 112(4):693-700. PubMed ID: 15382053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate receptor expression in pituitary adenomas cellular and molecular analysis.
    Evans CO; Yao C; Laborde D; Oyesiku NM
    Vitam Horm; 2008; 79():235-66. PubMed ID: 18804697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
    Lee ES; Na K; Bae YH
    J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucumber mosaic virus as drug delivery vehicle for doxorubicin.
    Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S
    Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.